Skip to the main content.
Request a Quote

Cell Microsystems Acquires Fluxion Biosciences to Broaden Cell Analysis Product and Services Portfolio. Read the Press Release

At Fluxion, we’re passionate about delivering cell-based solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Liquid Biopsy

Lab Services

YOUR STUDY. OUR TECHNOLOGY. IMMEDIATE RESULTS

Fluxion provides analytical services for a diverse range of liquid biopsy and CTC applications. Our Lab Services programs enables you to get results quickly and efficiently using Fluxion’s state-of-the-art technology and laboratory facilities. You design the study, we process and analyze the samples, you get the data…it’s that simple.

 

RECENT PROJECTS:

Optimization of a new capture antibody for prostate cancer

  • Liquid biopsy lab testing for a Phase II/III clinical trial of a novel pancreatic cancer therapeutic
  • NGS of cfDNA for ultra-sensitive liquid biopsy detection of lung cancer variants
  • Variant calling of existing NGS data using the ERASE-Seq pipeline
  • Custom NGS somatic mutation panel development for melanoma liquid biopsy
image-asset (1)

Why Use Our Lab Services

Your samples or ours…

Studies can be run with analytical samples and clinical samples (whole blood, apheresis, bone marrow aspirate). Clients can arrange for their own samples to be sent to our labs for processing, or Fluxion can source samples to your specifications from our network of clinicians.

image-asset (2)-1

cfDNA or CTCs…

Whether your interest is CTCs, cfDNA, or both; Fluxion has the technology. Our NGS solution, ERASE-Seq, delivers ultra-sensitive mutation detection by NGS for cfDNA samples. Fluxion provides CTC isolation using the IsoFlux System, offering the highest levels of cell recovery and purity, with a broad range of analysis options.

Oncology-1

You select the CTC isolation marker…

Thinking about moving beyond EpCAM? IsoFlux enables you to choose one or more markers to sequester cells from the bulk sample. Fluxion can run studies that include any combination of isolation markers such as EpCAM, EGFR, vimentin, N-cadherin, MUC1, and more.

Concept of biochemistry with dna molecule on blue background

A diverse range of downstream analysis options…

Fluxion offers a wide range of molecular analyses, including cfDNA and CTC sequencing, CTC enumeration, gene expression, protein marker detection, and more. Have your own analytical process? Fluxion can also prepare CTC samples for outside analysis by mounting on slides, recovering DNA/RNA, and complete NGS workflows with our ultra-sensitive ERASE-Seq technology. 

Cancer Code-1

Contact Us for a Proposal

A convenient, flexible, scalable model for liquid biopsy research…

Whether this is your first liquid biopsy study, or you’ve run numerous projects in this field, you’ll appreciate the flexibility our service model provides. No capital costs, no equipment training, and no operators required. Just contact us to request a proposal, and we’ll help you design a study that meets your study endpoints and budget.

Contact US